Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
Weighted Average Number of Shares Outstanding, Diluted: 2.82M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q3 EPS of ($0.10), $0.60 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $5.23 million versus the consensus estimate of $136.4 million.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue
- Oracle’s Ellison cancels plan to sell up to 50 mln shares
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
